Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Renal Failure With Hemodialysis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00742716
What this trial is testing

Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 41
Early research (Phase 1)Study completedNCT03873038
What this trial is testing

Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)

Who this might be right for
Renal DialysisKidney Failure, Chronic
Merck Sharp & Dohme LLC 38
Not applicableLooking for participantsNCT07522008
What this trial is testing

ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms

Who this might be right for
Chronic Kidney Disease 5DUremia; Chronic
Azienda Ospedaliera Brotzu 120
Not applicableLooking for participantsNCT06613568
What this trial is testing

Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants

Who this might be right for
End Stage Kidney Disease
Diality Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00646932
What this trial is testing

Paricalcitol Injection Phase II Trial

Who this might be right for
Chronic Kidney Disease
Abbott 25
Not applicableUnknownNCT06112821
What this trial is testing

Arteriovenous Fistula Maturation in Hemodialysis Patients With or Without Positive Antiphospholipid Antibodies

Who this might be right for
Chronic Kidney Diseases
Brugmann University Hospital 100
Not applicableUnknownNCT06688565
What this trial is testing

A Prospective, Multi-center Registry to Evaluate Safety and Efficacy of Hativ® ELectrocardiogram Monitoring on Patients with Hemodialysis

Who this might be right for
End-Stage Kidney DiseaseHemodialysis
Hallym University Medical Center 300
Post-approval studies (Phase 4)Study completedNCT02487706
What this trial is testing

Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease

Who this might be right for
HIV
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 5
Not applicableNot Yet RecruitingNCT06037759
What this trial is testing

Novel Cardiovascular Biomarkers in Patients With Kidney Disease

Who this might be right for
Haemodialysis ComplicationMajor Adverse Cardiac Events
Liverpool University Hospitals NHS Foundation Trust 100
Large-scale testing (Phase 3)Study completedNCT01932970
What this trial is testing

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 158
Not applicableStudy completedNCT04985383
What this trial is testing

Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis

Who this might be right for
End-Stage Renal Disease
Alkahest, Inc. 10
Large-scale testing (Phase 3)Looking for participantsNCT05410275
What this trial is testing

Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients

Who this might be right for
Chronic Hemodialysis Patients
University Hospital, Tours 10
Testing effectiveness (Phase 2)WithdrawnNCT02397395
What this trial is testing

An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.

Who this might be right for
Renal ImpairmentEnd-stage Renal Disease
Janssen R&D Ireland
Not applicableStudy completedNCT02684656
What this trial is testing

Reduction of Oxalate and Inflammation by Hemodiafiltration vs. Hemodialysis

Who this might be right for
Chronic Kidney Disease Requiring Chronic Dialysis
University of Erlangen-Nürnberg Medical School 14
Testing effectiveness (Phase 2)Study completedNCT01001351
What this trial is testing

PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Proteon Therapeutics 89
Not applicableStudy completedNCT03211676
What this trial is testing

Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer

Who this might be right for
End Stage Renal DiseaseDialysis Related ComplicationDialysis Amyloidosis
Poitiers University Hospital 49
Testing effectiveness (Phase 2)WithdrawnNCT01453634
What this trial is testing

Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)

Who this might be right for
Stage 5 Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)Hemodialysis (HD)
OPKO Health, Inc.
Large-scale testing (Phase 3)Study completedNCT00117052
What this trial is testing

SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Amgen 673
Post-approval studies (Phase 4)Study completedNCT03781089
What this trial is testing

Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients

Who this might be right for
HyperkalemiaEnd Stage Renal Disease
Duke University 36
Not applicableUnknownNCT04462614
What this trial is testing

Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

Who this might be right for
Chronic HemolysisVKAAnticoagulants / Administration & Dosage+7 more
CHU de Reims 49
Next Page